You are here

UK pharma sector stays immune to Brexit as innovation, scale spur deals

Sector being propelled in part by weaker pound and need to keep pipelines supplied with new, lucrative treatments

London

AS the United Kingdom's vote to leave the European Union wreaks havoc on the British economy, dealmaking momentum in the country's pharmaceutical industry is showing no signs of letting up.

Healthcare acquisitions in the UK have risen 21 per cent this year as total mergers

sentifi.com

Market voices on:

grab

Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at btsub.sg/promo

Powered by GET.comGetCom